nominally significantp = 0.009
Additional nominally significant pairwise interactions were identified with hyperglycemia (OR = 1.6; 95% CI: 1.14–2.37; p = 0.009), hypertriglyceridemia (OR = 2.6; 95% CI: 1.24–5.41; p = 0.011), and low HDL cholesterol (OR = 2.0; 95% CI: 1.12–4.11; p = 0.042), whereas the five-way interaction did not reach statistical significance (OR = 2.5; 95% CI: 0.88–6.96; p = 0.086).